Biosortia Pharmaceuticals, a Dublin-based subsidiary of Marysville-based Algaeventure Systems Inc. announced its CEO is Kurt Dieck

Columbus, Ohio (January 28, 2013) – A startup prospecting mucky ponds for the pharmaceutical promise has hired two top executives with Fortune 100 experience. Biosortia Pharmaceuticals, a Dublin-based subsidiary of Marysville-based Algaeventure Systems Inc. announced its CEO is Kurt Dieck, who until late 2011 was senior vice president of strategy and business execution at Cardinal Health Inc. (NYSE: CAH).